Reply to: Key Considerations for the Lenvatinib-Pembrolizumab-Chemotherapy Regimen in Advanced Gastric Cancer: Insights From LEAP-015
J Clin Oncol
.
2026 Feb;44(4):346.
doi: 10.1200/JCO-25-02148.
Epub 2025 Dec 11.
Authors
Kohei Shitara
1
;
LEAP-015 Investigators
1
Affiliation
1
Kohei Shitara, MD, National Cancer Center Hospital East, Kashiwa, Japan.
PMID:
41380104
DOI:
10.1200/JCO-25-02148
No abstract available